| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/24/2005 | WO2005016323A2 Use of c-kit inhibitors for treating type ii diabetes |
| 02/24/2005 | WO2005016255A2 Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds |
| 02/24/2005 | WO2004087194A3 Use of a dg931 protein for treating diabetes, obesity and metabolic syndrome |
| 02/24/2005 | WO2004080450A3 Combined use of a fibrate and orlistat for the treatment of obesity |
| 02/24/2005 | WO2004071403A3 Coated particles and pharmaceutical dosage forms |
| 02/24/2005 | WO2004047831A3 Use of a pparalpha agonist and metformin for decreasing the serum triglycerides |
| 02/24/2005 | WO2004031175A3 N-substituted-2-oxodihydropyridine derivatives as npy antagonists |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043408 Prevent protein glycation; drug screening; using epinephrine compound |
| 02/24/2005 | US20050043406 Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043373 Tyrosine phosphatase inhibitor; antidiabetic agents; insulin resistance; obesity |
| 02/24/2005 | US20050043362 Use of compounds |
| 02/24/2005 | US20050043360 Method for obtaining pioglitazone as an antidiabetic agent |
| 02/24/2005 | US20050043341 For stimulation of reverse cholesterol transport, lowering low density lipoproteins in blood; for treatment of hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, arteriosclerosis adiposity and obesity stroke or Alzheimer's disease |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/24/2005 | US20050043249 New pyrazole derivatives and diabetic medicine containing them |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043238 Exendin formulations for weight reduction |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050043226 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 02/24/2005 | US20050042754 Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042315 Paget's disease; antitumor agents; osteoporesis; nutrient mixture of plant extract and calcium compound |
| 02/24/2005 | US20050042302 Using organic acid salts for lactate degradation |
| 02/24/2005 | US20050042256 Food mixture; dietetics |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2535242A1 Use of c-kit inhibitors for treating type ii diabetes |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/23/2005 | EP1508566A1 (2s)-2-ethylphenylpropionic acid derivative |
| 02/23/2005 | EP1508340A1 Insulin resistance improving agents |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507853A1 Palliative treatment for gluten intolerance |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0941114B1 Use of glp-1 peptides |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | CN1585900A Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585604A Compositions for appetite control and related methods |
| 02/23/2005 | CN1583773A Preparing method for raffinose calcium and use for raffinose as calcium-supplementing agent |
| 02/23/2005 | CN1583750A Use of 2-3-methylen-dioxy dibenzo [a, g] quinolizine onium chloride in treatment of diabete |
| 02/23/2005 | CN1583747A Pterin mononitrogen monoxide synthase inhibitor |
| 02/23/2005 | CN1583746A Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
| 02/23/2005 | CN1583161A Health care product of bee adhesive |
| 02/23/2005 | CN1583160A Biological nutrient liquid for reducing blood fat and dissolving embolism and its preparation |
| 02/23/2005 | CN1583154A Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst |